# Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

> **NCT07307989** · PHASE2 · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Ischemic Stroke
- Hypercholesteremia

## Interventions

- **DRUG:** statin + ezetimibe
- **DRUG:** Statin monotherapy (rosuvastatin or atorvastatin)

## Key facts

- **NCT ID:** NCT07307989
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07307989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07307989, "Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07307989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*